Teva Floated As Bellwether In Generic Drug Price-Fixing MDL

By Matthew Santoni (February 21, 2020, 4:45 PM EST) -- A case brought by 44 state attorneys general against Teva Pharmaceuticals and several other drugmakers should be the bellwether for a massive multidistrict litigation over alleged conspiracies to fix the prices of generic drugs, according to a special master's report Thursday.

Even though the Teva suit was filed later than some of the others in the Pennsylvania-centered MDL, it covers a longer period, includes the overarching conspiracy allegedly meant to drive up drug costs, and could set more precedents than another case against Heritage Pharmaceuticals Inc., according to the report and recommendation from Special Master David H. Marion of White and...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!